Navigation Links
Angiotech's Corporate Partner, Boston Scientific, Reports Canadian Approval for TAXUS(R) Liberte(R) Stent System
Date:4/18/2008

VANCOUVER, April 18 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP), a global specialty pharmaceutical and medical device company, today reported that its corporate partner, Boston Scientific Corporation "BSC" (NYSE: BSX) has received approval for the sale of its TAXUS Liberte paclitaxel-eluting coronary stent system in Canada. BSC reported that Health Canada's Therapeutic Products Directorate (TPD), the authority that regulates pharmaceutical drugs and medical devices, has approved its use. BSC said it plans to launch the product immediately in Canada.

"The TAXUS Liberte Stent is a major advance in stent development and raises the bar for drug-eluting stent systems," said Serge Doucet, M.D., Cathlab Director at the Montreal Heart Institute. "It offers enhanced ability to conform to the vessel wall and deliver across some of the most challenging lesions. This innovation is welcome news for interventional cardiologists and patients in Canada who suffer from coronary artery disease."

"As Boston Scientific develops new platforms, we are excited to see that our technology continues to be leveraged in the next-generation of drug-eluting stents and pleased that Canadian physicians and patients can now benefit from the TAXUS Liberte for the treatment of coronary artery disease," said Dr. William Hunter, President and CEO of Angiotech.

Currently the leading drug-eluting stents worldwide, TAXUS Stent Systems have been evaluated by the industry's most extensive randomized, c
'/>"/>

SOURCE Angiotech Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
2. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
3. Vical Names Andrew de Guttadauro Vice President, Corporate Development
4. Signalife Provides Corporate Update
5. Biomira Announces Plan to Reincorporate in the United States
6. Pressure BioSciences, Inc. Provides Corporate Update
7. The 4th Annual BIO Investor Forum to Webcast Alexzas Corporate Presentation
8. Clinsys Clinical Research, Inc. Announces Relocation of Corporate Headquarters
9. ProMed Alliance International Inc. Corporate Name and Trading Symbol Expected to Change Effective Tomorrow
10. MultiCell Technologies Signs Worldwide Exclusive License Agreement With Corning Incorporated
11. New Corporate Website Launched - Focus on Life Scientists, Flow Cytometrists, & Clinicians

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... , TUSTIN, Calif., Dec. 2 /PRNewswire-FirstCa...PHM ) today reported completion of patient enrollm...Cotara® in patients with relapsed glioblastom...ncer. Cotara is a targeted monoclonal antibody li...ial new treatment for GBM. Cotara specifically ta...
(Date:12/2/2009)... , JERUSALEM, Israel, December 2 /PRN...ity study evaluating the preclinical (animal study...ich combines technology from Weill,Cornell Medical...ential to,treat inherited anemias such as Cooley,s...ries of technologies to expand, ex vivo,populatio...
(Date:12/2/2009)... , SHANGHAI, Dec. 2 /PRNewswire-Asia/ -- ...rkets are in turmoil and uncertainty is part of ma...e pharma industry has been,relatively immune to th...a,vacation. , During the midst of the dif...ohnson & Johnson inaugurated an R&D center...
(Date:12/1/2009)... , NEW YORK, Dec. 1 Report...port is available in its catalogue: ,, Chromi...rtlinker.com/p0164494/Chromium---Global-Market-Tre...rimarily influenced by stainless steel, while grow... is also important for growth of chromium metal. E...
Breaking Biology Technology:Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3Reportlinker Adds Chromium - Global Market Trends 2Reportlinker Adds Chromium - Global Market Trends 3Reportlinker Adds Chromium - Global Market Trends 4Reportlinker Adds Chromium - Global Market Trends 5Reportlinker Adds Chromium - Global Market Trends 6Reportlinker Adds Chromium - Global Market Trends 7Reportlinker Adds Chromium - Global Market Trends 8Reportlinker Adds Chromium - Global Market Trends 9
...er,therapeutics company, announced today that Timo...Chief Scientific Officer., "We are thrilled that ... A. Olson, President and CEO at Mersana. "His exte...rience with polymer-based drug systems are an,idea...impact he will have,on our newest programs, his co...
...America, Inc. (OTC Bulletin Board: CBAI), the umbi...http://www.cordblood-america.com ) focused on,brin...milies nationwide and,internationally, today annou... by the leading biotechnology publication in Greec...hip in 2006 named a.bourkas Co.,United., "Stem ce...
...,Inc. (eRT), (Nasdaq: ERES ), a leading provider ...on and interpretation services including,expert co...and services,(electronic data capture and electron... today that it will release its 2007 fourth quarte...n Tuesday, February 26,2008 after the market close...
Other Biology Technology:Mersana Therapeutics, Inc. Appoints Chief Scientific Officer, Timothy B. Lowinger, Ph.D. 2Cord Blood America CEO Matthew Schissler Interviewed by BIONOVA, Greece's Leading Biotech Magazine 2eResearchTechnology, Inc. to Announce 2007 Fourth Quarter Results on February 26, 2008 2
(Date:12/3/2009)...t dwellers must be included in the design of the u...d a humanitarian crisis, according to a scientist ... Nature , Dr Simon Lewis argues that at least 50% ...nhagen, known as REDD (Reducing Emissions from Def...est dwellers directly, and their property rights a...
(Date:12/3/2009)...0-year record low in Antarctic snowmelt that occur...ue to concurrent strong positive phases for two ma...ation) and SAM (Southern Hemisphere Annular Mode),...or of Earth & Atmospheric Sciences at The City Col...also on the doctoral faculty at the CUNY Graduate ...
(Date:12/2/2009)...LADELPHIA Cigarette smoking and alcohol consumpti...predicts the patient,s future risk of death, accor...tudy show a similar effect among those who continu...cancer survivors are counseled to quit smoking; de...cent continued to smoke even after their cancer di...
Breaking Biology News(10 mins):Forest deal at Copenhagen must avoid creating 'carbon refugees' 2CCNY professor foresees rising Antarctic snowmelt 2Head and neck cancer survivors who use alcohol and cigarettes have increased death risk 2Pittsburgh G 2O Explained 3A Watch Penn State Experts on YouTube 56028 1Pittsburgh G 2O Explained 3A Watch Penn State Experts on YouTube 56028 2SHPS Wins Nine Healthcare Communication Awards in the 2009 Health Information Awards Program 56025 1SHPS Wins Nine Healthcare Communication Awards in the 2009 Health Information Awards Program 56025 2A Mediterranean Approach to Flavorful Living 56023 1A Mediterranean Approach to Flavorful Living 56023 2A Mediterranean Approach to Flavorful Living 56023 3
...ggest and most aggressive male claims the alpha ma...ut a new study from the University of Minnesota su...ore mild-mannered males can also use political beh...as gleaned from 10 years of observing dominant mal...oking at behaviors they used to compete for alpha ...
... You don,t have to get wet, or seasick, to find ou...wide. Just tune in through your computer. , This ...arth available to computers everywhere was launc...rancisco. Scientists at UC Santa Barbara are invol...te at UCSB played a key role in providing scientif...
...astating lodgepole pine stands across the West mig...f flakes containing a natural substance used in he...owding host trees, according to a team of scientis...ed study appear in the February issue of Forest E... California and Idaho, and showed how applications...
Other Biology News:Small male chimps use politics, rather than aggression, to lead the pack, U of Minnesota study says 2New version of Google Earth features California's marine protected areas 2Landscape-scale treatment promising for slowing beetle spread 2
Gey's Balanced Salt Solution (GBSS) from Sigma-Aldrich
...difications to the original formulas in efforts to... play an important role in tissue,culture. A salt ...osmotic balance in the medium and to provide the c...s valuable today as when it was first developed a ...
Ellman's Reagent from Cayman Chemical
Synergy HT Multi-Detection Microplate Reader from BioTek Instruments
Biology Products: